← back to search

Arianne C. Richard

Cancer Research UK Cambridge Center · GB
Area of research
Immunology · Oncology
Research interest
Research interests include Biology, Cell biology, Stimulation, Computational biology, Innate lymphoid cell, and Innate immune system.
h-index
citations
859
works
9
NIH funding
primary concept
email

Recent publications

Super‐killer CTLs are generated by single gene deletion of Bach2
European Journal of Immunology 2022cited by 6position: middledoi
Staggered starts in the race to T cell activation
Trends in Immunology 2021cited by 16position: firstdoi
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell anti-metastatic function in the lung
The Journal of Immunology 2021cited by 2position: middledoi
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung
Nature Immunology 2020cited by 161position: middledoi
Stimulation strength controls the rate of initiation but not the molecular organisation of TCR-induced signalling
eLife 2020cited by 23position: lastdoi
Detection and removal of barcode swapping in single-cell RNA-seq data
Nature Communications 2018cited by 368position: middledoi
Correcting the Mean-Variance Dependency for Differential Variability Testing Using Single-Cell RNA Sequencing Data
Cell Systems 2018cited by 119position: middledoi
T cell cytolytic capacity is independent of initial stimulation strength
Nature Immunology 2018cited by 97position: firstdoi
PIP5 Kinases Regulate Membrane Phosphoinositide and Actin Composition for Targeted Granule Secretion by Cytotoxic Lymphocytes
Immunity 2018cited by 67position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2018–2022)John C. Marioni · European Bioinformatics Institute5 papers (2018–2020) · 3 papers (2018–2021)Aaron T. L. Lun · Walter and Eliza Hall Institute of Medical Research2 papers (2018–2018)Martijn J. Schuijs · Cancer Research UK Cambridge Center2 papers (2020–2021)Julie Stockis · Cancer Research UK Cambridge Center2 papers (2020–2021)E. Suzanne Cohen · AstraZeneca (Singapore)2 papers (2020–2021)Matthew Eldridge · Cancer Research UK Cambridge Center2 papers (2020–2021)Gordon L. Frazer · University of Bristol2 papers (2018–2021) · 2 papers (2020–2021)Silvain Pinaud · Cancer Research UK Cambridge Center2 papers (2020–2021)Kevin M. Brindle · Cancer Research UK Cambridge Center2 papers (2020–2021)Jacqueline D. Shields · University of Nottingham2 papers (2020–2021)Richard J. A. Goodwin · University of Glasgow2 papers (2020–2021)Eva Serrão · Cambridge University Hospitals NHS Foundation Trust2 papers (2020–2021) · 2 papers (2020–2021)Céline Garcia · University of Edinburgh2 papers (2020–2021)Angela Riedel · University of Würzburg2 papers (2020–2021)Shaun Png · Cancer Research UK Cambridge Center2 papers (2020–2021)Hans‐Reimer Rodewald · German Cancer Research Center1 papers (2020–2020)